CIVB vs CRL · P/E 9.5, rev $10.5M vs rev $2.00B
Civista Bancshares Inc (CIVB) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Civista Bancshares Inc (CIVB) is a banks - regional company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported CIVB revenue for 2026-06-30 was $10.5M. Net income was $29.3M. CIVB currently screens at market cap $531.6M and trailing P/E 9.5.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
CIVB currently screens at market cap $531.6M and trailing P/E 9.5. CRL currently screens at market cap $7.78B.
Not investment advice. Open the CIVB and CRL stock pages for the full models.
Not investment advice.